MedTrace Logo

Clinical Effectiveness of Topical Autologous Platelet Gel for the Treatment of Venous Ulcers

NCT00273234 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2007-03-06

No results posted yet for this study

Summary

The purpose of this study is to compare the effectiveness of standard venous ulcer care to standard venous ulcer care plus a cell based product made from the patients own blood. This product, Autologous Platelet Concentrate (APC), is a concentrate of cells in the bloodstream called platelets.

Conditions

  • Venous Ulcer

Interventions

PROCEDURE

Autologous Platelet Gel (APG)

Sponsors & Collaborators

  • National Healing Corporation

    lead INDUSTRY

Principal Investigators

  • Bob Bartlett, MD · National Healing Corporation

  • Steve Martin, PhD Candidate, Health Science · Touro University International

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2006-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00273234 on ClinicalTrials.gov